Search

Your search keyword '"Thomas Tursz"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Thomas Tursz" Remove constraint Author: "Thomas Tursz"
166 results on '"Thomas Tursz"'

Search Results

1. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.

2. EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

4. [Not Available]

5. Implications of personalized medicine—perspective from a cancer center

6. Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?

7. Towards Quality, Comprehensiveness and Excellence. The Accreditation Project of the Organisation of European Cancer Institutes (OECI)

8. Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

9. Nuclear Localization of Apoptosis Protease Activating Factor-1 Predicts Survival after Tumor Resection in Early-Stage Non–Small Cell Lung Cancer

10. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients

11. Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-Up

12. Malignant effusions and immunogenic tumour-derived exosomes

13. Hurdles on the road to personalized medicine

14. Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community?

15. Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition

16. Longitudinal Follow-up of Cellular and Humoral Immunity Induced by Recombinant Adenovirus-Mediated Gene Therapy in Cancer Patients

17. Dendritic cell-based immunotherapy of cancer

18. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

19. Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells

20. Therapy-Induced Tumor Immunosurveillance Involves IFN-Producing Killer Dendritic Cells

21. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

22. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells

23. Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience

24. Tobacco: deadly in any form or disguise

25. Intracellular Signaling Events in CD77-Mediated Apoptosis of Burkitt's Lymphoma Cells

26. In vivo veritas

27. Curbing tobacco's toll starts with the professionals: World No Tobacco Day

28. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences

29. Immunological approaches in the gene therapy of cancer

30. The fate of human CD77+ germinal center B lymphocytes after rescue from apoptosis

31. Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes

32. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism

33. Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

34. A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancer

36. WIN Consortium--challenges and advances

37. Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx

38. Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ

39. Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial

40. Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer

41. Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levels

42. Does malignant small round cell tumor of the thoracopulmonary region (askin tumor) constitute a clinicopathologic entity?. An analysis of 30 cases with immunohistochemical and electron-microscopic support treated at the institute gustave roussy

43. Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

44. Gap Junction Communication between Autologous Endothelial and Tumor Cells Induce Cross-Recognition and Elimination by Specific CTL

45. Analysis of phenotypic and functional changes during ganglioside-induced inhibition of human T cell proliferation

46. Primary Prostatic Wilmsʼ Tumor

47. A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma

48. Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiation

49. Imatinib mesylate (Gleevec): targeted therapy against cancer with immune properties

50. Need for global action for cancer control

Catalog

Books, media, physical & digital resources